TWST Kronos AI forecast
A 30-trading-day price forecast for Twist Bioscience Corporation (TWST) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Twist Bioscience Corporation at $110.61 on 2026-12-08, −30.8% from the last close of $159.85 on 2026-10-27. Eight out of ten sampled paths end between $74.16 and $133.32, and 0 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of TWST
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $153.74 | $147.28 | $157.12 |
| 2026-11-10 | $145.05 | $128.64 | $159.90 |
| 2026-11-17 | $137.05 | $100.84 | $152.09 |
| 2026-11-24 | $122.12 | $80.05 | $148.46 |
| 2026-12-01 | $123.60 | $73.35 | $135.24 |
| 2026-12-08 | $110.61 | $74.16 | $133.32 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for TWST?
- Kronos AI's median forecast for TWST is $110.61 in 30 trading days, −30.8% from the last close, with a 10–90% range of $74.16 to $133.32.
- Is the TWST Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- AMGN — Amgen Inc.
- GILD — Gilead Sciences Inc.
- MRNA — Moderna Inc.
- ARGX — argenx SE American Depositary Shares
- RVMD — Revolution Medicines Inc.
- BIIB — Biogen Inc.